Tag: NCDs

The Joint IFRC-IFPMA Reception on the occasion of the 67th World Health Assembly
Bringing psoriasis into light
Health at your fingertips
IFPMA joins ITU and WHO in Be He@lthy, Be Mobile mHealth initiative to reduce the impact of non-communicable diseases (NCDs)
EB 133, Item 6.2, Psoriasis
WHA 66 agenda item 13.2 on draft action plan for the prevention and control
A vibrant pipeline for unmet medical needs
Addressing the gaps in global policy and research for non-communicable diseases
R&D-based pharmaceutical industry and International Federation of Red Cross and Red Crescent Societies join forces to prevent NCDs
Introduction - Mario Ottiglio, director, public affairs and global health policy, IFPMA
Putting NCDs into focus
IFPMA Framework for Action on NCDs
A shared commitment to improving global health
Health by the Numbers shows the research-based pharmaceutical industry ‘walks the talk’ on health promotion
The New Frontiers of Biopharmaceutical Innovation
Health by the numbers: results of the 2011 IFPMA wellness survey
Global pharmaceutical industry contributes action plan and research to fighting NCDs in the developing world
Research-based pharmaceutical industry launches collaborative framework to tackle NCDs
Research-based pharmaceutical industry welcomes WHA outcome on vaccines, fake medicines and NCDs
WHA 64, Item 13.12, Prevention and control of non-communicable diseases
Russians evidently overestimate their state of health as good and fair
Woman & child health partnerships for the developing world
Improving access to medicines for non-communicable diseases in the developing world
WHPA health improvement card
A shared commitment to fight non-communicable disease
Population attitude to personal health: perception of health, understanding of risk factors, morbidity and mortality

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Assembly Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Clinical Trials Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 COVID-19 vaccines Dementia Developing World Diabetes Economic footprint Efficacy Epidemics Ethics Event Highlights Fake Medicines Fakes Fight the Fakes Flu Global Health global health security harmonization Health Partnerships HIV/AIDS IFPMA IFPMA Statement Immunization Incremental Innovation Influenza Influenza Vaccination Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Transparency Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers